Immuto Scientific Announces $8M Seed 2 Financing and Daiichi Sankyo Collaboration to Uncover a New Class of Therapeutic Targets with Structural Surfaceomics
Immuto Scientific unveils collaboration with Daiichi Sankyo to identify cancer‑specific cell‑surface targets MADISON, Wis. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Immuto Scientific announced today the closing of an oversubscribed $8 million Seed 2 financing round and a drug…